Log In
    News

    Onconova Therapeutics (ONTX) NobleCon17 Presentation Replay

    1/21/2021
    Health
    0 min read

    Onconova Therapeutics (ONTX) CEO Steven Fruchtman at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Steven to moderate a Q&A session.

    NobleCon 17 Complete Rebroadcast
    Share
    Related News
    ‌
    AstraZeneca Acquires FibroGen’s China Business for $160 Million, Expanding Presence in Anemia Market
    2/20/2025
    Health

    AstraZeneca Acquires FibroGen’s China Business for $160 Million, Expanding Presence in Anemia Market

    AstraZeneca (AZN) has announced a $160 million acquisition of FibroGen’s (FGEN) China business, securing regional rights to the oral anemia drug roxadustat. This deal strengthens AstraZeneca’s footprint in the Chinese...
    3 min read
    ‌
    Release – Direct Digital Holdings Introduces A New Framework to Help Businesses Manage AI Adoption in the Workplace
    2/20/2025
    Media and Marketing

    Release – Direct Digital Holdings Introduces A New Framework to Help Businesses Manage AI Adoption in the Workplace

    Direct Digital Holdings, Inc. (Nasdaq: DRCT) (“Direct Digital Holdings” or the “Company”), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC (“Colossus SSP”) and Orange...
    4 min read
    ‌
    Release – SKYX Will Supply Its Advanced Smart Plug & Play Technologies to Three Upcoming Ultra-High-End Luxury Projects of Forte Developments
    2/20/2025
    Consumer

    Release – SKYX Will Supply Its Advanced Smart Plug & Play Technologies to Three Upcoming Ultra-High-End Luxury Projects of Forte Developments

    SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive smart platform technology company with more than 97 issued and pending patents globally and over...
    5 min read
    ‌
    Release – V2X to Sustain Electronic Warfare Systems for U.S. Air Force
    2/20/2025
    Aerospace and Defense

    Release – V2X to Sustain Electronic Warfare Systems for U.S. Air Force

    V2X Inc., (NYSE: VVX) has been awarded a $21 million firm-fixed-price contract to continue sustaining critical avionics and electronic warfare systems for the U.S. Air Force. The contract supports the...
    3 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In